William Blair Weighs in on 908 Devices Q1 Earnings

908 Devices Inc. (NASDAQ:MASS) – Analysts at William Blair issued their Q1 2026 earnings per share estimates for shares of 908 Devices in a report issued on Tuesday, January 14th. William Blair analyst M. Larew expects that the company will post earnings of ($0.37) per share for the quarter. The consensus estimate for 908 Devices’ current full-year earnings is ($1.99) per share. William Blair also issued estimates for 908 Devices’ Q2 2026 earnings at ($0.31) EPS, Q3 2026 earnings at ($0.28) EPS and Q4 2026 earnings at ($0.24) EPS.

Several other brokerages have also recently issued reports on MASS. Stifel Nicolaus decreased their target price on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Stephens restated an “overweight” rating and set a $6.00 price objective on shares of 908 Devices in a research report on Wednesday. Leerink Partners reiterated a “market perform” rating and issued a $4.00 target price (down previously from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Finally, Leerink Partnrs downgraded 908 Devices from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 13th.

908 Devices Trading Up 47.0 %

NASDAQ MASS opened at $2.91 on Thursday. The stock has a 50 day moving average price of $2.41 and a 200-day moving average price of $3.53. 908 Devices has a one year low of $1.81 and a one year high of $8.50.

Institutional Trading of 908 Devices

A number of large investors have recently modified their holdings of MASS. SG Americas Securities LLC purchased a new position in shares of 908 Devices during the third quarter valued at $36,000. B. Riley Wealth Advisors Inc. bought a new position in 908 Devices during the 3rd quarter worth about $45,000. Drive Wealth Management LLC purchased a new position in 908 Devices during the 3rd quarter valued at about $50,000. Townsquare Capital LLC bought a new stake in shares of 908 Devices in the 3rd quarter valued at about $50,000. Finally, 49 Wealth Management LLC lifted its position in shares of 908 Devices by 16.2% in the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock worth $108,000 after purchasing an additional 4,343 shares during the period. Hedge funds and other institutional investors own 88.06% of the company’s stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.